Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Interferon Beta and Glatiramer Acetate Therapy.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study.
Multiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study.
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction.
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications.
Cine cerebrospinal fluid imaging in multiple sclerosis.
[Current immunotherapy of multiple sclerosis].
[Spinal anesthesia for cesarean section in a patient with multiple sclerosis].
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.
Detection of reduced interhemispheric cortical communication during task execution in multiple sclerosis patients using functional near-infrared spectroscopy.
Evidence for a two-stage disability progression in multiple sclerosis.
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)
Altered inter-subregion connectivity of the default mode network in relapsing remitting multiple sclerosis: a functional and structural connectivity study.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial.
Pages
« first
‹ previous
…
199
200
201
202
203
204
205
206
207
…
next ›
last »